Psychedelic Medicine the Therapeutic Potential of MIND-Altering Substances
Psychedelic Medicine: The Therapeutic Potential of Mind-Altering Substances is a course offered by the University of Maastricht.
Provider
Details
Enrollment
Course Overview
Psychedelic Medicine The Therapeutic Potential of Mind-Altering Substances is a course offered by the Faculty of Psychology and Neuroscience at Maastricht University that embarks students on a journey exploring the transformative potential of psychedelics in the therapeutic landscape.
Spanning from their long-standing traditional use by ancient cultures to their modern application in psychiatric treatment, the course provides a comprehensive overview of the development and current status of psychedelic research. Students delve into the historical context, understanding how Western societal trends in the mid-20th century led to the stigmatization and prohibition of these substances, consequently stunting scientific exploration into their effects for decades.
This class also addresses the surge of interest in the late 20th and early 21st centuries, spotlighting emerging research labs across the globe that are now unfolding the largely untapped therapeutic potential of psychedelics.
The course is not just a historic exploration but a forward-looking endeavour, preparing future practitioners for an evolving field of study. It equips students with the ability to define psychedelics and explain their neurobiological mechanisms, imparting knowledge about the varied effects of these substances on cognition, mood, and social behaviour.
Students will also learn to articulate the potential therapeutic applications of psychedelics and reflect upon psychiatric conditions that might benefit from such treatments. Amidst this newfound interest and increasing demand for effective, alternative treatments, the course instils a sense of responsibility among students, teaching them to communicate objectively about these substances' benefits and risks to lay audiences and patients.
About the Provider
While Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.
View Maastricht University profileCourse Details
- PriceFree
- FormatLive Classes
- Lifecycle statusActive
- Skillsdefining psychedelicsexplaining neurobiologyunderstanding historical contextdifferentiating effectsassessing therapeutic applicationsconducting psychedelic researchcommunicating effectively
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Add Spravato® to Your Practice with Our 8-Phases Implementation Roadmap
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Advanced Training
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.
Next cohort: May 20, 2026
Self-paced access